This review highlights the concept that agents that improve NOS coupling and signaling through sGC to directly target the endothelial dysfunction could serve as potential therapies to alleviate the maternal symptoms of PE to prolong pregnancy in severe PE (Figure 1). Here, NOS1 is linked to endothelial dysfunction.